DelveInsight’s ‘Vascular Dementia -Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of Vascular Dementia historical and forecasted epidemiology as well as the Vascular Dementia market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
The Vascular Dementia market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Vascular Dementia market size from 2019 to 2032. The Report also covers current treatment practice, market drivers, market barriers, SWOT analysis, reimbursement and market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Some of the key facts of the Vascular Dementia Market Report:
Key benefits of the Vascular Dementia Market report:
Got queries? Click here to know more about the Vascular Dementia Market Landscape
Vascular Dementia Overview
The word dementia describes a set of symptoms that can include memory loss and difficulties with thinking, problem-solving, or language. In vascular dementia, these symptoms occur when the brain is damaged because of problems with blood supply to the brain. Vascular dementia is an etiological category of dementia characterized by severe cognitive impairment resulting from ischemic or hemorrhagic stroke or hypoperfusion affecting brain regions important for memory, cognition, and behavior. Vascular dementia is a decline in thinking skills caused by conditions that block or reduce blood flow to various brain regions, depriving them of oxygen and nutrients. Cognition and brain function can be significantly affected by the size, location, and number of vascular changes.
A growing number of experts prefer the term “vascular cognitive impairment” (VCI) to “vascular dementia” because they feel it better expresses the concept that vascular thinking changes can range from mild to severe. According to the Vascular Impairment of Cognition Classification Consensus Study (VICCCS) guideline, can be classified into four major subtypes: Post-stroke dementia (PSD) defined as dementia manifesting within 6 months after a stroke; Subcortical ischemic vascular dementia; Multi-infarct (cortical) dementia; and mixed dementia.
Caused by different conditions that interrupt the flow of blood and oxygen supply to the brain and damage blood vessels in the brain.
Vascular Dementia Epidemiological Insights:
Vascular Dementia Epidemiological Segmentation
Vascular Dementia Market Outlook
Vascular dementia is a common condition with no effective approved pharmacological treatments available. Vascular dementia arises from ischemic insults such as hemorrhage and hypoperfusion that trigger neurodegeneration by depriving nerve cells of oxygen and glucose.
has multifactorial etiopathology, diverse clinical manifestations, and multiple clinical subtypes. Moreover, the diagnostic criteria are not consistent worldwide.
Although patients with constitute the second-largest dementia population, treatment data are lacking. There are no effective pharmacological compounds approved for the treatment of vascular dementia in any jurisdiction worldwide. Controlling medical conditions that impact cardiovascular health is recommended to prevent further decline. For example, medications can be prescribed to control blood pressure, cholesterol, heart disease, and diabetes. Aspirin or other drugs may be prescribed to prevent clots from forming in blood vessels
According to DelveInsight, the Vascular Dementia treatment paradigm in the 7MM is expected to change during the forecasted period 2022–2032.
Learn more by requesting for sample @Vascular Dementia Market Landscape
Vascular Dementia Key Companies
Vascular Dementia Therapies
Table of Contents
Click here to read more about Vascular Dementia Market
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Gaurav BoraEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/